<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recently, there has been enormous growth in the clinical importance of the <z:e sem="disease" ids="C0949691" disease_type="Disease or Syndrome" abbrv="SPDA1">spondyloarthropathies</z:e>, in part because of their close association with HLA, and in part because of the recognition that a substantial number of patients suffer from different forms of these disorders </plain></SENT>
<SENT sid="1" pm="."><plain>Over the years, immunogeneticists, geneticists, epidemiologists, bacteriologists, membrane biologists, and clinicians have joined in the attempt to clarify our understanding of <z:e sem="disease" ids="C0038013" disease_type="Disease or Syndrome" abbrv="">ankylosing spondylitis</z:e>, <z:e sem="disease" ids="C0035012" disease_type="Disease or Syndrome" abbrv="">Reiter's disease</z:e>, psoriatic <z:hpo ids='HP_0003040'>arthropathy</z:hpo>, and other interrelated conditions </plain></SENT>
<SENT sid="2" pm="."><plain>This article provides a summary of clinical and research developments in what is now recognized as a major area in rheumatology </plain></SENT>
</text></document>